The Market With the Highest Initial Listing Standards in the World
On July 1, 2006, the NASDAQ National Market will be renamed the NASDAQ Global Market. In conjunction with this, NASDAQ will create the new NASDAQ Global Select Market, a segment of the NASDAQ Global Market with the highest initial listing standards of any exchange in the world based on financial and liquidity requirements.
"Mannatech is an example of an industry leader that has achieved superior listing standards, which clearly defines the essence of the NASDAQ Global Select Market," said NASDAQ's Bruce Aust, Executive Vice President, Corporate Client Group. "NASDAQ is focused on leading a race to the top in terms of listing qualifications. In recognizing these companies, we are highlighting their achievement in meeting the requirements to be included in the market with the highest listing standards in the world," added Mr. Aust.
Read more...
A new science- Glycobiology has emerged! Eight specific sugars (glyconutrients) have been identified for the support of proper cell structures, processes, and functions (Harper's Biochemistry, 24th ed.). A blend of these eight innate-sugars from plant-rich sources has been developed, along with an entire line of products based on this amazing discovery! Are you ready to rediscover "wellness?"
Wednesday, June 28, 2006
Monday, June 19, 2006
Company Infringes on Patented Glyconutritional Technology
Techmedica Health Inc. has been sued for manufacturing, selling and using a glyconutritional product, under the brand name Nutratose, that violates the patented glyconutritional technology.
The glyconutrient technology is supported by substantial investment in areas such as research and development, product refinement, quality control and regulatory compliance. The company employs a growing staff of doctors, researchers, chemists and health science professionals dedicated to helping develop unique, technologically superior products.
Read more...
Techmedica Health Inc. has been sued for manufacturing, selling and using a glyconutritional product, under the brand name Nutratose, that violates the patented glyconutritional technology.
The glyconutrient technology is supported by substantial investment in areas such as research and development, product refinement, quality control and regulatory compliance. The company employs a growing staff of doctors, researchers, chemists and health science professionals dedicated to helping develop unique, technologically superior products.
Read more...
Subscribe to:
Posts (Atom)